JAZZ vs NMPAR
Jazz Pharmaceuticals PLC (JAZZ) versus NMP Acquisition Corp. Right (NMPAR) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
NMP Acquisition Corp. Right (NMPAR) common stock listed on US.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
NMPAR does not have a complete income-statement cache yet.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. NMPAR currently screens at market cap $0.
Not investment advice. Open the JAZZ and NMPAR stock pages for the full models.
Not investment advice.